Atty Lies Shouldn't Doom $200M IP Win, Merck Tells Justices
Merck has asked the U.S. Supreme Court to review the Federal Circuit's upholding of a decision that wiped out a $200 million patent verdict it won against Gilead over hepatitis C...To view the full article, register now.
Already a subscriber? Click here to view full article